The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study

M. O. Becker; C. Brückner; H. U. Scherer; N. Wassermann; J. Y. Humrich; L. G. Hanitsch; U. Schneider; A. Kawald; K. Hanke; G. R. Burmester; Gabriela Riemekasten

doi:10.1136/ard.2010.137935

The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study

M. O. Becker, C. Brückner, H. U. Scherer, N. Wassermann, J. Y. Humrich, L. G. Hanitsch, U. Schneider, A. Kawald, K. Hanke, G. R. Burmester, Gabriela Riemekasten^*

^*Corresponding author for this work

Clinic of Rheumatology

27 Citations (Scopus)

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	70
Issue number	7
Pages (from-to)	1340-1341
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/ard.2010.137935
Publication status	Published - 07.2011

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Access to Document

10.1136/ard.2010.137935

Cite this

Becker, M. O., Brückner, C., Scherer, H. U., Wassermann, N., Humrich, J. Y., Hanitsch, L. G., Schneider, U., Kawald, A., Hanke, K., Burmester, G. R., & Riemekasten, G. (2011). The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study. Annals of the Rheumatic Diseases, 70(7), 1340-1341. https://doi.org/10.1136/ard.2010.137935

@article{7dff7bb3185e4e96aa682f4a47fe2cc7,

title = "The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study",

author = "Becker, {M. O.} and C. Br{\"u}ckner and Scherer, {H. U.} and N. Wassermann and Humrich, {J. Y.} and Hanitsch, {L. G.} and U. Schneider and A. Kawald and K. Hanke and Burmester, {G. R.} and Gabriela Riemekasten",

year = "2011",

month = jul,

doi = "10.1136/ard.2010.137935",

language = "English",

volume = "70",

pages = "1340--1341",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

number = "7",

}

Becker, MO, Brückner, C, Scherer, HU, Wassermann, N, Humrich, JY, Hanitsch, LG, Schneider, U, Kawald, A, Hanke, K, Burmester, GR & Riemekasten, G 2011, 'The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study', Annals of the Rheumatic Diseases, vol. 70, no. 7, pp. 1340-1341. https://doi.org/10.1136/ard.2010.137935

TY - JOUR

T1 - The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study

AU - Becker, M. O.

AU - Brückner, C.

AU - Scherer, H. U.

AU - Wassermann, N.

AU - Humrich, J. Y.

AU - Hanitsch, L. G.

AU - Schneider, U.

AU - Kawald, A.

AU - Hanke, K.

AU - Burmester, G. R.

AU - Riemekasten, Gabriela

PY - 2011/7

Y1 - 2011/7

UR - http://www.scopus.com/inward/record.url?scp=79957663518&partnerID=8YFLogxK

U2 - 10.1136/ard.2010.137935

DO - 10.1136/ard.2010.137935

M3 - Letters

C2 - 21068100

AN - SCOPUS:79957663518

VL - 70

SP - 1340

EP - 1341

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 7

ER -

The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study

Research Areas and Centers

Access to Document

Other files and links

Cite this